Show simple item record

dc.contributor.authorMurphy, Richard A*
dc.contributor.authorSunpath, Henry*
dc.contributor.authorLu, Zhigang*
dc.contributor.authorChelin, Neville*
dc.contributor.authorLosina, Elena*
dc.contributor.authorGordon, Michelle*
dc.contributor.authorRoss, Douglas*
dc.contributor.authorEwusi, Aba D*
dc.contributor.authorMatthews, Lynn T*
dc.contributor.authorKuritzkes, Daniel R*
dc.contributor.authorMarconi, Vincent C*
dc.date.accessioned2012-12-11T23:38:27Z
dc.date.available2012-12-11T23:38:27Z
dc.date.issued2010-04-24
dc.date.submitted2011-03-22
dc.identifier.citationAIDS;2010;24(7):1007-12en
dc.identifier.issn1473-5571
dc.identifier.pmid20397305
dc.identifier.urihttp://hdl.handle.net/10144/255398
dc.descriptionArticle approval pending
dc.description.abstractTo determine initial 24-week outcomes among prospectively enrolled patients with failure of initial antiretroviral therapy (ART).
dc.language.isoenen
dc.relation.urlhttp://journals.lww.com/aidsonline/Abstract/2010/04240/Outcomes_after_virologic_failure_of_first_line_ART.9.aspxen
dc.rightsPublished by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluweren
dc.subject.meshAdulten
dc.subject.meshAnti-HIV Agentsen
dc.subject.meshAnti-Retroviral Agentsen
dc.subject.meshCD4 Lymphocyte Counten
dc.subject.meshDrug Resistance, Viralen
dc.subject.meshFemaleen
dc.subject.meshGenotypeen
dc.subject.meshHIV Infectionsen
dc.subject.meshHIV-1en
dc.subject.meshHumansen
dc.subject.meshMaleen
dc.subject.meshMiddle Ageden
dc.subject.meshMutationen
dc.subject.meshProspective Studiesen
dc.subject.meshSouth Africaen
dc.subject.meshTreatment Failureen
dc.subject.meshViral Loaden
dc.titleOutcomes After Virologic Failure of First-Line ART in South Africaen
dc.typeArticleen
dc.contributor.departmentOperational Support Unit, Doctors Without Borders, New York, New York; McCord Hospital, Durban, South Africa; Massachusetts General Hospital, Boston, Massachusetts, USA; Nelson Mandela School of Medicine, Durban; St. Mary’s Hospital, Mariannhill, South Africa; Harvard Medical School; Division of Infectious Diseases, Beth Israel Deaconess Medical Center; Section of Retroviral Therapeutics, Brigham and Women’s Hospital, Boston, Massachusetts; Infectious Disease Service, San Antonio Military Medical Center, Fort Sam Houston, Texas; Emory University School of Medicine, Atlanta, Georgia, USAen
dc.identifier.journalAIDSen
refterms.dateFOA2019-03-04T10:07:45Z
html.description.abstractTo determine initial 24-week outcomes among prospectively enrolled patients with failure of initial antiretroviral therapy (ART).


Files in this item

Thumbnail
Name:
Murphy Outcomes after virologic ...
Size:
131.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record